First Heartland Consultants’s Bristol-Myers Squibb BMY Stock Holding History

First Heartland Consultants’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,119	Closed	-$216K	–	376
2023 Q1	$216K	Sell	3,119 -878	-22%	-$61.9K	0.03%	332
2022 Q4	$288K	Sell	3,997 -964	-19%	-$72.7K	0.05%	286
2022 Q3	$352K	Sell	4,961 -9,742	-66%	-$707K	0.03%	225
2022 Q2	$1.13M	Sell	14,703 -15,372	-51%	-$1.17M	0.18%	108
2022 Q1	$2.2M	Buy	30,075 +1,568	+6%	+$105K	0.34%	62
2021 Q4	$1.78M	Buy	28,507 +3,190	+13%	+$187K	0.07%	79
2021 Q3	$1.5M	Buy	25,317 +179	+0.7%	+$11.8K	0.23%	96
2021 Q2	$1.68M	Buy	25,138 +2,741	+12%	+$179K	0.25%	94
2021 Q1	$1.41M	Buy	22,397 +18,943	+548%	+$1.18M	0.22%	104
2020 Q4	$214K	Buy	+3,454	New	+$212K	0.04%	316
2017 Q4	–	Sell	-7,333	Closed	-$467K	–	275
2017 Q3	$467K	Buy	7,333 +494	+7%	+$28.8K	0.11%	226
2017 Q2	$381K	Buy	6,839 +1,195	+21%	+$65K	0.1%	235
2017 Q1	$307K	Sell	5,644 -283	-5%	-$15.5K	0.09%	250
2016 Q4	$346K	Sell	5,927 -1,307	-18%	-$71.5K	0.11%	235
2016 Q3	$390K	Buy	7,234 +907	+14%	+$58.3K	0.11%	200
2016 Q2	$465K	Buy	6,327 +1,956	+45%	+$138K	0.05%	163
2016 Q1	$279K	Sell	4,371 -1,449	-25%	-$91.4K	0.11%	204
2015 Q4	$400K	Buy	5,820 +183	+3%	+$12.1K	0.15%	162
2015 Q3	$334K	Buy	5,637 +2,061	+58%	+$131K	0.14%	165
2015 Q2	$238K	Sell	3,576 -149	-4%	-$9.82K	0.06%	219
2015 Q1	$240K	Buy	3,725 +197	+6%	+$12.3K	0.09%	214
2014 Q4	$208K	Buy	+3,528	New	+$199K	0.09%	228
2013 Q3	–	Sell	-4,619	Closed	-$206K	–	230
2013 Q2	$206K	Buy	+4,619	New	+$201K	0.12%	192

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

First Heartland Consultants's BMY Position: Q2 2023 in Review

First Heartland Consultants sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 3,119 shares — an estimated $216K sold.

First Heartland Consultants first reported a position in BMY in Q2 2013 and held it in 23 quarters. The position peaked at $2.2M in Q1 2022. 2,482 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

First Heartland Consultants reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
First Heartland Consultants sold 3,119 Bristol-Myers Squibb shares in Q2 2023, an estimated $216K.
First Heartland Consultants first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 23 quarters.
First Heartland Consultants's Bristol-Myers Squibb position peaked at $2.2M in Q1 2022.
2,482 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on First Heartland Consultants's 13F filing for Q2 2023, filed 26 Jul 2023.